PMID: 15228172Jul 2, 2004Paper

Implications of cytochrome P450 genetic polymorphisms on the toxicity of antitumor agents

Therapeutic Drug Monitoring
Ron H N van Schaik

Abstract

In the treatment of cancer, a narrow therapeutic window generally exists between toxicity and suboptimal therapy. In addition, interindividual variation in drug metabolism seriously complicates therapy. Genetic polymorphisms in phase 1 and phase 2 enzymes are present in the population and may explain part of the observed interindividual variation in drug pharmacokinetics. For the cytochrome P450 superfamily, information on variant alleles encoding enzymes with decreased activity is rapidly on the increase. The potential of applying pharmacogenetic screening before therapy in the treatment of cancer seems to be greatest for CYP2B6 (cyclophosphamide treatment), CYP2C8 (paclitaxel therapy), and CYP3A5; however, the drugs of interest still need to be identified for this latter enzyme.

References

Sep 17, 1977·Lancet·A MahgoubR L Smith
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R C SkodaU A Meyer
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·I JohanssonM Ingelman-Sundberg
Aug 27, 1998·Journal of the National Cancer Institute·T R RebbeckS B Malkowicz
May 26, 1999·Clinical Pharmacology and Therapeutics·T TateishiS Kobayashi
Sep 24, 1999·Journal of the National Cancer Institute·B AmirimaniT R Rebbeck
Dec 12, 2001·Pharmacogenetics·E HustertL Wojnowski
May 7, 2002·The Pharmacogenomics Journal·L IyerM J Ratain
Jul 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diederik F S KehrerAlex Sparreboom
Aug 2, 2002·Clinical Pharmacology and Therapeutics·Andrea GaedigkJ Steven Leeder
Aug 22, 2002·Journal of the National Cancer Institute·Ron H J MathijssenAlex Sparreboom
Sep 21, 2002·European Journal of Clinical Pharmacology·Masahiro HiratsukaMichinao Mizugaki
Oct 31, 2002·Advanced Drug Delivery Reviews·Jatinder K LambaKenneth E Thummel
Jan 18, 2003·Pharmacology & Toxicology·Akiko SoyamaJun-ichi Sawada
Mar 12, 2003·The Pharmacogenomics Journal·H-J XieA Rane
Oct 29, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Isa CavacoVera Ribeiro
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Akiko SoyamaJun-ichi Sawada

❮ Previous
Next ❯

Citations

Jul 26, 2005·Journal of Human Genetics·Barkur S Shastry
May 14, 2005·Pharmacology & Therapeutics·Thomas Efferth, Manfred Volm
Mar 1, 2006·Investigational New Drugs·J Lee VillanoLatha Radhakrishnan
Oct 13, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mikkel RosendahlMichael Andersson
May 20, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Ron H N van Schaik
Nov 11, 2006·Depression and Anxiety·Laura J Rasmussen-Torvik, Donna D McAlpine
Dec 20, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·N HariparsadP B Desai
Dec 14, 2005·Cancer Letters·Floris A de JongRon H J Mathijssen
Dec 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ron H J Mathijssen, Ron H N van Schaik
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean L GremRichard H Wilson
Jun 23, 2018·Current Medicinal Chemistry·Roberta Zilles HahnRafael Linden
Apr 17, 2020·Journal of Adolescent and Young Adult Oncology·Alini Trujillo-PaolilloSílvia R C Toledo
Mar 1, 2005·Personalized Medicine·Jeantine Lunshof

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.